TVTX
TVTX
US89422G1076
Travere Therapeutics, Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 490.728.000 233.175.000
110.5%
Cost of Revenue 10.339.000 7.744.000
33.5%
Gross Profit 480.389.000 225.431.000
113.1%
543.213.000 546.820.000
0.7%
Operating Income -62.824.000 -321.389.000
80.5%
Pretax Income -49.273.000 -320.510.000
84.6%
Net Income Common Stockholders -25.546.000 -321.545.000
92.1%
-- --
--
-- --
--
ende